Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation

Research output: Contribution to journalLetter

Authors

Colleges, School and Institutes

Details

Original languageEnglish
Pages (from-to)513-4
Number of pages2
JournalBlood Coagulation and Fibrinolysis
Volume14
Issue number5
Publication statusPublished - 1 Jul 2003